Perioral dermatitis
☆ I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
Papules faataamilo i le gutu ma poga'iisu ma sina mumu i tua e masani ona matauina i foliga o se patch poʻo pustule i le gutu.
References
Perioral dermatitis ose ma'i vaivai pa'u e masani ona va'aia i tama'ita'i talavou, e fa'ailoa mai i tama'i patu mūmū po'o ni fasi pa'u mago ma pa'u ile gutu. E ui e masani ona afaina ai le vaega o le gutu, e mafai foi ona aliali i tafatafa o mata ma isu, e tau atu i lona igoa tauvalaau, periorificial dermatitis. O le faʻaaogaina o vailaʻau faʻamaʻi i luga o foliga e mafai ona faʻaosoina ai lenei tulaga, o lea o le laasaga muamua i togafitiga e masani lava ona taofi le faʻaogaina o nei steroids. O isi togafitiga e aofia ai le fa'aogaina o le metronidazole po'o le calcineurin inhibitors, po'o le tagofia o vaila'au tetracycline oral. O le perioral dermatitis e masani ona tali lelei i togafitiga, ae e mafai i nisi taimi ona tumau pe toe foʻi faʻafia.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
O le Propolis o se mea lipophilic e maua mai i laʻau e pi. O le fa'amoemoega o lenei lipoti o le fa'amatalaga o le fa'aalia lea o le taua o lenei vaila'au e mafua ai le cheilitis fa'afeso'ota'i allergic. Na fa'asea se tama'ita'i e 21-tausaga le matua ile eczema perioral pruritic mo le 5 tausaga. I masina ua mavae na aafia ai foi le ua. Ina ua uma ona maua le contact dermatitis, sa tuuina atu o ia i se suega patch. O le i'uga o le su'ega fa'apipi'i na matua'i lelei mo propolis (++) .
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
O fa'ama'i pa'u 'ese'ese e fa'aalia e papules erythematous. Fa'ama'i masani ile falema'i - folliculitis, rosacea ; Fa'ama'i e seasea tupu - eosinophilic pustular folliculitis (EPF) , granulomatous periorificial dermatitis (GPD) , lupus miliaris disseminatus faciei (LMDF) .
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
O vailaʻau faʻamaʻi e mafai ona mafua ai le maʻi ma o mea faʻasusu ma mea teuteu e mafai foi ona fesoasoani i le atinaʻeina o faʻamaʻi paʻu. O togafitiga e masani lava e ala i le taofi o vailaʻau faʻamaʻi ma mea teuteu, ma i tulaga sili atu ona ogaoga, ave le tetracyclines i le gutu. O le taofi o vaila'au fa'ama'i e ono fa'ateteleina ai le mageso.
O le tulaga ua fuafuaina e aafia ai le 0.5-1% o tagata i le tausaga i le lalolagi atiaʻe. E oo atu i le 90% o i latou ua aafia o tamaitai i le va o le 16 ma le 45 tausaga.
○ Togafitiga ― OTC Drugs
O le dermatitis perioral e masani ona mafua mai i le ma'i fa'afeso'ota'i tumau o mea teuteu, o lea e le fautuaina ai le fa'aogaina o mea teuteu i le gutu. O le tagofia o le OTC antihistamine atonu e fesoasoani. Togafitiga masani e mana'omia ile tele o masina.
#OTC antihistamine